Vidac Pharma Holding Plc (ETR:T9G)
Germany · Delayed Price · Currency is EUR 0.4080
-0.0050 (-1.21%)
At close: Oct 8, 2026
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €21.06 million as of October 8, 2026. It is the 35,879th most valuable company in the world and the 475th biggest in Germany.
Market Cap
21.06M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#475 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 21.06M, a decrease of -21.54%. That is a compound annual growth rate of -25.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 21.06M | -23.88% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 86.40M |
| 2invest AG | 43.75M |
| Biomark Diagnostics | 34.71M |
| Paion AG | 367.39K |
| bioXXmed AG | 271.87K |
| co.don AG | 213.79K |
| Medigene AG | 71.46K |